Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation

Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2019-03, Vol.123 (6), p.948-955
Hauptverfasser:	López Otero, Diego, Ávila-Carrillo, Alejandro, González Ferreiro, Rocío, Cid Menéndez, Adrián, Iglesias Álvarez, Diego, Álvarez Rodríguez, Leyre, Antúnez Muiños, Pablo, Álvarez, Belén Cid, Sanmartín Pena, Xoan Carlos, Gómez Pérez, Fernando, Diéguez, Alfredo Redondo, Cruz-González, Ignacio, Trillo Nouche, Ramiro, González-Juanatey, José Ramón
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Aortic valve Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - epidemiology Aortic Valve Stenosis - surgery Cardiology Cardiovascular disease Clinical medicine Comorbidity Congestive heart failure Coronary Angiography Coronary artery Coronary artery disease Coronary Artery Disease - diagnosis Coronary Artery Disease - epidemiology Coronary Artery Disease - surgery Coronary vessels Echocardiography Female Follow-Up Studies Heart Heart failure Humans Implantation Intervention Male Medical prognosis Morbidity Patients Percutaneous Coronary Intervention - methods Prognosis Registries Retrospective Studies Rheumatic heart disease Risk Assessment - methods Risk Factors Severity of Illness Index Spain - epidemiology Stents Survival Rate - trends Syntax Time Factors Transcatheter Aortic Valve Replacement - methods Transplants & implants Variables
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients who underwent TAVI. Patients underwent TAVI from 2008 to 2016 were included in the study. Baseline SYNTAX score and residual SYNTAX score (rSS) after percutaneous coronary intervention were calculated. Based on rSS, patients were classified as complete revascularization (rSS = 0), reasonably incomplete revascularization (rSS >0 and
ISSN:	0002-9149 1879-1913
DOI:	10.1016/j.amjcard.2018.12.007